Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.989080
Abstract: Background Cholangiocarcinoma (CCA) is a malignant tumor originating from bile duct epithelial cells that no obvious clinical symptoms and specific clinical manifestations are shown in the early stage of CCA. Methods Propensity score matching (PSM)… read more here.
Keywords: propensity score; patients cca; losartan group; patients losartan ... See more keywords